Violet Therapeutics

Polku Therapeutics

This company develops small-molecule drugs to treat neurodegenerative disorders such as Parkinson's and Alzheimer's disease for patients and pharmaceutical partners.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

Parkinnova Therapeutics

This company develops small molecule phosphodiesterase inhibitors to replenish dopamine and slow disease progression for patients with Parkinson’s disease.

Polku Therapeutics Oy

This company develops small molecule therapies targeting neurodegenerative diseases for patients with conditions including Alzheimer's, Parkinson's and progressive supranuclear palsy.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Polku Therapeutics Oy

This company develops small molecule therapies targeting neurodegenerative diseases for patients with conditions such as dementia, Parkinson's and traumatic brain injury.

Vanqua Bio

This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.